Advertisement

Topics

Latest "Therapeutics Medical Equipment Deals Alliances Profile Updated 14022017" News Stories

08:35 EST 21st February 2019 | BioPortfolio

Here are the most relevant search results for "Therapeutics Medical Equipment Deals Alliances Profile Updated 14022017" found in our extensive news archives from over 250 global news sources.

More Information about Therapeutics Medical Equipment Deals Alliances Profile Updated 14022017 on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about Therapeutics Medical Equipment Deals Alliances Profile Updated 14022017 for you to read. Along with our medical data and news we also list Therapeutics Medical Equipment Deals Alliances Profile Updated 14022017 Clinical Trials, which are updated daily. BioPortfolio also has a large database of Therapeutics Medical Equipment Deals Alliances Profile Updated 14022017 Companies for you to search.

Showing "Therapeutics Medical Equipment Deals Alliances Profile Updated 14022017" News Articles 1–25 of 44,000+

Thursday 21st February 2019

Spacelabs Healthcare Receives $8 Million Order for Monitoring and Telemetry Upgrade Project

Spacelabs Healthcare (“Spacelabs” or the “Company”) today announced that it has been selected to complete a whole-house replacement of patient monitoring and telemetry equipment at a Level I Trauma Center in the western U.S. The project spans 43 departments and includes Spacelabs’ central stations, high-acuity bedside and transport monitors, as well as ...


Stents Related Implants Global Market Research and Forecast, 20152025 [Report Updated: 01011970] Prices from USD $2200

SummaryThe Stents Related Implants report provides an independent information about the Stents Related Implants industry supported by extensive research on factors such as industry segmentssize trends, inhibitors, dynamics, drivers, opportunities challenges, environment policy, cost overview, porter's five force analysis, and key companies profiles including business overview and recent dev...

Liquid Technology Provides Theranos with Post-Shutdown Equipment Processing and Recycling

The Company Spearheaded the Biotech Start-Up’s Task of Decommissioning and Reselling of Thousands of Unneeded IT Assets Liquid Technology, an industry leading IT asset disposition service provider, announces their instrumental role in coordinating and executing Theranos’ equipment and asset retirement as a result of the company’s liquidati...


Magenta Therapeutics Presents Preclinical Data on MGTA-145, First-Line Stem Cell Mobilization Product Candidate for Autologous and Allogeneic Bone Marrow Transplant

-- A single dose of MGTA-145 plus plerixafor mobilized two to three times more stem cells in non-human primates than multi-day regimen of current standard of care G-CSF -- -- Cells mobilized with MGTA-145 plus plerixafor rapidly engrafted in non-human primates following autologous transplant -- -- MGTA-145-mobilized cells from non-human p...

New Virta Health Results Add Improved Sleep as Benefit of the Virta Treatment

Emerging Evidence Suggests that Sleep Quality Improves with Virta Health’s Novel Care Model and Intervention for Type 2 Diabetes Reversal Virta Health, the first company with a treatment to safely and sustainably reverse type 2 diabetes (T2D) without the use of medications or surgery, today announced the publication of new peer-reviewed research in

Carol J. Burt Joins IQVIA Board of Directors

IQVIA™ (NYSE:IQV) today announced the appointment of Carol J. Burt to its board of directors, effective today. A principal of private investment firm Burt-Hilliard Investments for more than a decade, Burt is a former executive officer of WellPoint, Inc. (now Anthem, Inc.), lastly as Senior Vice President, Corporate Finance and Development, and previ...

Aimmune Therapeutics to Host Conference Call and Webcast to Discuss Fourth Quarter and Full-Year 2018 Financial Results and Recent Operational Highlights

Aimmune Therapeutics, Inc. (Nasdaq:AIMT), a biopharmaceutical company developing treatments for life-threatening food allergies, today announced that it will host a conference call on Thursday, February 28, 2019, at 5:00 p.m. ET to discuss its financial results for the quarter and full-year ended December 31, 2018, and recent operational highlights. ...

Senior Housing Properties Trust Announces Alpharetta Medical Center Achieves BOMA 360 Designation

Senior Housing Properties Trust (Nasdaq: SNH) today announced that its Alpharetta Medical Center property, located at 1360 Upper Hembree Road, Roswell, Georgia, has been designated as a 360 Performance Building by the Building Owners and Managers Association (BOMA) International Program Council. The BOMA 360 Performance Progr...

Millendo Therapeutics, Inc. to Present at the 8th Annual SVB Leerink Global Healthcare Conference

Millendo Therapeutics, Inc. (Nasdaq: MLND), a clinical-stage biopharmaceutical company developing novel treatments for orphan endocrine diseases, announced today that Julia C. Owens, Ph.D., President and Chief Executive Officer, will present at the 8th Annual SVB

Certara Launches Version 19.1 of its D360 Scientific Informatics Platform

New release includes tools to enhance biologics research and workflows, as well as enabling analyses to improve critical research decision-making Certara®, the global leader in model-informed drug development, regulatory science, real-world evidence and market access services, today announced the launch of version 19.1 of its flagship scientific ...

Polypropylene PP Filler Masterbatch Global Market Research and Forecast, 20152025 [Report Updated: 01011970] Prices from USD $2200

SummaryThe Polypropylene PP Filler Masterbatch report provides an independent information about the Polypropylene PP Filler Masterbatch industry supported by extensive research on factors such as industry segmentssize trends, inhibitors, dynamics, drivers, opportunities challenges, environment policy, cost overview, porter's five force analysis, and key companies profiles including business o...

Rigid Polyurethane Foam RPUF Global Market Research and Forecast, 20152025 [Report Updated: 01011970] Prices from USD $2200

SummaryThe Rigid Polyurethane Foam RPUF report provides an independent information about the Rigid Polyurethane Foam RPUF industry supported by extensive research on factors such as industry segmentssize trends, inhibitors, dynamics, drivers, opportunities challenges, environment policy, cost overview, porter's five force analysis, and key companies profiles including business overview and re...

Rainier Therapeutics to Participate in the SVB Leerink Global Healthcare Conference

Rainier Therapeutics, Inc., a privately-held clinical stage drug development company, today announced that Scott Myers, Chairman and Chief Executive Officer, will present at the 8th Annual SVB Leerink Global Healthcare Conference on Wednesday, February 27, 2019 at 1:30 p.m. ET (10:30 a.m. PT) at the Lotte New York Palace in New York City. About Ra...

$CRSP Proposes New Members to the Board of Directors https://finance.yahoo.com/news/crispr-therapeutics-proposes-members-board-120000589.html …

$CRSP Proposes New Members to the Board of Directors https://finance.yahoo.com/news/crispr-therapeutics-proposes-members-board-120000589.html …

New machine learning technique rapidly analyzes nanomedicines for cancer immunotherapy

With their ability to treat a wide a variety of diseases, spherical nucleic acids (SNAs) are poised to revolutionize medicine. But before these digitally designed nanostructures can reach The post New machine learning technique rapidly analyzes nanomedicines for cancer immunotherapy appeared first on Compelo Medical Devices.

ResMed, Fisher & Paykel Healthcare announce settlement of global patent infringement litigation

The settlement involves no payment or admission of liability by either side. Under the agreement, all ongoing infringement proceedings against named products will be dismissed, and each party The post ResMed, Fisher & Paykel Healthcare announce settlement of global patent infringement litigation appeared first on Compelo Medical Devices.

OptiBiotix cholesterol product 'generally recognised as safe' by US independent expert panel

OptiBiotix Health plc (LON:OPTI) said its cholesterol product had been generally recognised as safe (GRAS) by an independent expert panel in the US. OptiBiotix Chief Executive Stephen O’Hara tells Proactive London why the company, which is developing products to tackle obesity, cardiovascular disease and diabetes, said sign-off for its Lactobacillus plantarum LPLDL probiotic strain represented...

Relief of Heartburn in Patients With Erosive Esophagitis

Does a new potassium-competitive acid blocker, vonoprazan, provide more rapid relief of heartburn than standard treatment with a proton-pump inhibitor? Alimentary Pharmacology & Therapeutics

ArQule to Present at the 8th Annual Leerink Partners Global Healthcare Conference on February 28, 2019

ArQule, Inc. (Nasdaq: ARQL) today announced that Paolo Pucci, Chief Executive Officer, and Brian Schwartz, M.D., Chief Medical Officer and Head of Research and Development, of ArQule will present at the 8th Annual Leerink Partners Global Healthcare Conference on February 28, 2019, at 11:30 a.m. ET at the Lotte New York Palace in New York City. The...

ArQule to Report Fourth Quarter and Full Year 2018 Financial Results on March 7, 2019

ArQule, Inc. (Nasdaq: ARQL) today announced it will report financial results for the fourth quarter and full year of 2018 before the market opens on Thursday, March 7, 2019. The Company will hold a conference call and webcast on the same day at 9:00 a.m. ET to discuss these results and provide a general business update. The live webcast can be acc...

Ra Pharmaceuticals to Present at the 8th Annual SVB Leerink Global Healthcare Conference

Ra Pharmaceuticals, Inc. (Nasdaq:RARX) today announced that Ramin Farzaneh-Far, M.D., Chief Medical Officer of Ra Pharma, will present at the 8th Annual SVB Leerink Global Healthcare Conference on Thursday, February 28, 2019 at 2:30 p.m. E.T. The conference is being held at the Lotte New York Palace, New York, NY. The presentation will be webcast ...

CHA Health Systems Subsidiary to Form the Largest Healthcare Network to Provide Premium Comprehensive Suite of Medical Services

CHS increased the share of SMG to approximately 24% to form the largest healthcare network in the Asia-Pacific region to develop a world-class oncology program, wellness center, and women’s health center CHA Health Systems (CHS), a global leader in bio-technology and

Landos Biopharma Announces Publication Supporting Novel, Dual Mechanism of Action for BT-11 in Models of IBD

Landos Biopharma, Inc., a clinical-stage biopharmaceutical company focused on the discovery and development of first-in-class oral therapeutics for patients with autoimmune diseases, announced the publication of findings that further elucidate the regulatory arm of the novel mechanism of action for BT-11, its investigational new

MPM Capital Raises $400 Million to Fund Early-Stage Biotech Innovation

MPM Capital, a life-sciences venture capital firm investing in early-stage therapeutics companies, announced today the closing of its seventh venture fund, BioVentures 2018 (BV2018). MPM is currently investing out of BV2018 and its two oncology-only funds with a total of over $1 billion in capital. With BV2018, MPM will continue to create and inve...

Fresenius Medical Care AG & Co. KGaA: Fresenius Medical Care published form 20-F for the fiscal year 2018

DGAP-News: Fresenius Medical Care AG & Co. KGaA / Key word(s): Miscellaneous 21.02.2019 / 11:51 The issuer is solely responsible for the content of this announcement. February 21, 2019 Fresenius Medical Care published form 20-F for the fiscal year 2018 Fresenius Medical Care, the world's largest provider of dialysis products and services, announced that it has filed the annual report ...


Advertisement
Quick Search
Advertisement
Advertisement

 

News Quicklinks